Tech Company Financing Transactions

Pervasis Therapeutics Funding Round

Pervasis Therapeutics closed a $5 million financing round on 12/31/2006. Investors included Flagship Pioneering, Highland Capital Partners and Polaris Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

One Kendall Square B6101
Cambridge, MA 02139
USA

Phone

(617) 621-3407

Website

www.pervasistx.com

Email Address

[email protected]

Overview

Pervasis Therapeutics is focused on creating biologically active vascular technologies to treat significant unmet needs in cardiovascular disease.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Frederic Chereau

        

Co-Founder

Helen Nugent

        

VP - Bus. Development

Margaret O'Toole

        

VP - Manufacturing

Jack Harvey

        

Browse more venture capital transactions:

Prev: 12/31/2006: SemiSouth Laboratories venture capital transaction
Next: 12/31/2006: VoodooVox venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary